WebNUCALA is not indicated for the relief of acute bronchospasm or status asthmaticus. 1.2 Eosinophilic Granulomatosis with Polyangiitis . NUCALA is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). 2 DOSAGE AND ADMINISTRATION . NUCALA is for subcutaneous (SC) use only. 2.1 Severe Asthma WebMar 8, 2024 · NUCALA injection is intended for use under the guidance of a healthcare provider. The 100-mg/mL prefilled autoinjector and 100-mg/mL prefilled syringe are only for use in adults and adolescents aged 12 years and older. A patient may self-inject or the patient caregiver may administer NUCALA injection 100 mg/mL subcutaneously after the ...
Nucala: Package Insert / Prescribing Information
WebThe specialty pharmacies listed below are currently participating in the specialty pharmacy network for NUCALA. Which pharmacy is used may vary based on your health insurance plan. AcariaHealth (Centene) 800-511-5144. Accredo Health Group, Inc. 877-222-7336. Aetna Specialty Pharmacy 866-782-2779. AllianceRx Walgreens-Prime 888-347-3416. WebThe following assistance programs may be available for your patients: Gateway to NUCALA can help evaluate patient options. Call 844-4-NUCALA ( 844-468-2252) Monday through Friday, 8 AM to 8 PM ET. The NUCALA Co-pay Program can help eligible patients covered by commercial insurance pay as little as $0 for NUCALA (maximum of $15,000 for 12 … populous event inc
FDA approves Nucala (mepolizumab) 40 mg prefilled syringe for …
Webtreatment of adult and pediatric patients aged 12 years and older with hypereosinophilic syndrome (HES) for ≥6 months without an identifiable non-hematologic secondary cause. Severe asthma trials: headache, injection site reaction, back pain, fatigue. CRSwNP trial: oropharyngeal pain, arthralgia. EGPA and HES trials (300 mg of NUCALA): no ... WebDec 23, 2024 · Incidence not known. Blurred vision. chest tightness. confusion. cough. difficulty with breathing. dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position. fast heartbeat. hives or welts, itching, or skin rash. WebSecondary endpoint: NUCALA patients achieved lower daily steroid dose during the last 4 weeks of treatment (OR: 0.20; 95% Cl: 0.09, 0.41). 1. SOC was defined as OCS +/– immunosuppressants. After Week 4, OCS (prednisolone or prednisone) dose could be tapered, per physician judgment or a suggested protocol. Remission was defined as … populous kansas city layoffs